Atlas of Genetics and Cytogenetics in Oncology and Haematology


Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

LPHN2 (latrophilin 2)

Identity

Other namesLPHH1
LEC1
KIAA0786
HGNC LPHN2
Location 1p31.1
Location_base_pair Starts at 82038670 and ends at 82230695 bp from pter ( according to hg18-Mar_2006).
Local_order --ELTD1---LPHH1----FLJ23033----PRKACB--

DNA/RNA

 
  Representation of the genomic structure of LPHH1. Black blocks represent core exons which are present in the majority of gene transcripts. The yellow blocks represent alternatively spliced coding exons which may be incorporated variably in transcripts derived from different cell types/tissues or as a consequence of differing cellular states. The red boxes represent the presence of multiple, in some cases tissue-specific, leader exons that have been identified for this gene, an observation consistent with the existence of multiple dispersed promoter elements. The most variably spliced region of the coding sequence was the carboxy-terminal domain D.
Description LPHH1 consists of 19 commonly used coding exons. A further seven exons have been identified which may be alternatively spliced into the core backbone with variable frequencies and tissue specificities. At least a number of these additional exons are highly conserved in mammalian species. The core exons (ATG, exon 1 to stop, exon 19) span a region of about 154kb. However, the 5'end of the gene is not precisely defined with transcripts in different tissues apparently initiating from specific locations over an extensive region. The most distant leader exon identified (foetal lung) lies approximately 390kb from exon 1 which makes the total size of the gene at least 550kb.
Transcription Expression has been observed by RT-PCR in all normal tissues and lines tested with the clear exception of lymphocytes and lymphoblastoid cells. Strongest expression was observed in foetal lung, normal adult lung and thyroid. Alternative splicing to some degree in at least one domain (minimally the carboxy-terminal domain D) was seen in each tissue and line examined with human brain showing a characteristic pattern and additional variability in the other three coding sequence domains.
Pseudogene No known pseudogene.

Protein

 
  Alternative splicing in domain D dramatically alters the structure of the carboxy-terminus of the encoded protein, latrophilin 2. Variable splicing in this region occurs in all tissues and cell lines tested.
Description LPHH1 encodes a putative seven-span transmembrane receptor with atypically large extra membrane N (predicted to be extra-cellular) and C termini. In addition to the seven hydrophobic membrane spanning domains, a putative lectin-like region is present near the N-terminus.
Expression Protein likely to be ubiquitously expressed in adherent cells but that has not so far been confirmed. Human brain-specific alternative splices alter the structure of the extra-membrane, intra-cellular loop between TM domains 5 and 6, a region thought to be critical for G-protein/receptor interactions.
Localisation Likely to be plasma membrane.
Function Likely role in coupling cell adhesion to cell signalling.
Homology Latrophilin 2 is part of a small sub-family of 7TMs which includes latrophilins 1 and 3. Latrophilin 1 is the receptor for Black Widow spider toxin: -latrotoxin.

Mutations

Note None reported.

Implicated in

Entity Breast carcinoma
Note Analysis of breast cancer cell lines has demonstrated dramatic differences in transcript levels between certain lines. In one case, strong expression was allelically imbalanced.
  
Entity Lung carcinoma
Note strong expression in normal lung was reduced in 55% (35/64) of matched primary non-small cell lung carcinomas (NSCLC). Over-representation was not scored in any tumour, nor in any lung cancer cell line tested and transcript was undetectable by RT-PCR in one line (1/15) and very low in a further two. Loss of heterozygosity was scored in 8/16 informative NSCLC lesions. Primary and SCLC lines showed a characteristic pattern of alternative splicing.
  

External links

Nomenclature
HGNCLPHN2   18582
Entrez_GeneLPHN2  23266  latrophilin 2
Cards
AtlasLPHH1ID313
GeneCardsLPHN2
EnsemblLPHN2 [Search_View]   ENSG00000117114 [Gene_View]
GenatlasLPHN2
GeneLynxLPHN2
eGenomeLPHN2
euGene23266
Genomic and cartography
GoldenPathLPHN2  -  1p31.1   chr1:82038670-82230695 +  1p31.1   [Description]    (hg18-Mar_2006)
EnsemblLPHN2 - 1p31.1 [CytoView]
NCBIMapview
OMIMDisease map [OMIM]
HomoloGeneLPHN2
Gene and transcription
GenbankAB018329 [ ENTREZ ]
GenbankAF104266 [ ENTREZ ]
GenbankAF104938 [ ENTREZ ]
GenbankAF104939 [ ENTREZ ]
GenbankAJ131581 [ ENTREZ ]
RefSeqNM_012302 [ SRS ]    NM_012302 [ ENTREZ ]
RefSeqAC_000044 [ SRS ]    AC_000044 [ ENTREZ ]
RefSeqAC_000133 [ SRS ]    AC_000133 [ ENTREZ ]
RefSeqNC_000001 [ SRS ]    NC_000001 [ ENTREZ ]
RefSeqNT_032977 [ SRS ]    NT_032977 [ ENTREZ ]
RefSeqNW_001838579 [ SRS ]    NW_001838579 [ ENTREZ ]
RefSeqNW_921351 [ SRS ]    NW_921351 [ ENTREZ ]
AceViewLPHN2 AceView - NCBI
UnigeneHs.24212 [ SRS ]    Hs.24212 [ NCBI ]     HS24212 [ spliceNest ]
Fast-db16655 (alternative variants)
Protein : pattern, domain, 3D structure
SwissProtO95490 [ SRS]    O95490 [ EXPASY ]     O95490 [ INTERPRO ]     O95490 [ UNIPROT ]
PrositePS00649 G_PROTEIN_RECEP_F2_1 [ SRS ]    PS00649 G_PROTEIN_RECEP_F2_1 [ Expasy ]
PrositePS00650 G_PROTEIN_RECEP_F2_2 [ SRS ]    PS00650 G_PROTEIN_RECEP_F2_2 [ Expasy ]
PrositePS50227 G_PROTEIN_RECEP_F2_3 [ SRS ]    PS50227 G_PROTEIN_RECEP_F2_3 [ Expasy ]
PrositePS50261 G_PROTEIN_RECEP_F2_4 [ SRS ]    PS50261 G_PROTEIN_RECEP_F2_4 [ Expasy ]
PrositePS50221 GPS [ SRS ]    PS50221 GPS [ Expasy ]
PrositePS51132 OLF [ SRS ]    PS51132 OLF [ Expasy ]
PrositePS50228 SUEL_LECTIN [ SRS ]    PS50228 SUEL_LECTIN [ Expasy ]
InterproIPR001879 GPCR_2_extracellular [ SRS ]    IPR001879 GPCR_2_extracellular [ EBI ]
InterproIPR003924 GPCR_2_latrophilin [ SRS ]    IPR003924 GPCR_2_latrophilin [ EBI ]
InterproIPR003334 GPCR_2_latrophilin_rcpt_C [ SRS ]    IPR003334 GPCR_2_latrophilin_rcpt_C [ EBI ]
InterproIPR000832 GPCR_2_secretin-like [ SRS ]    IPR000832 GPCR_2_secretin-like [ EBI ]
InterproIPR000922 Lectin_gal_bd [ SRS ]    IPR000922 Lectin_gal_bd [ EBI ]
InterproIPR003112 Olfac_like [ SRS ]    IPR003112 Olfac_like [ EBI ]
InterproIPR000203 PKD_cys_rich [ SRS ]    IPR000203 PKD_cys_rich [ EBI ]
CluSTrO95490
PfamPF00002 7tm_2 [ SRS ]    PF00002 7tm_2 [ Sanger ]    pfam00002 [ NCBI-CDD ]
PfamPF02140 Gal_Lectin [ SRS ]    PF02140 Gal_Lectin [ Sanger ]    pfam02140 [ NCBI-CDD ]
PfamPF01825 GPS [ SRS ]    PF01825 GPS [ Sanger ]    pfam01825 [ NCBI-CDD ]
PfamPF02793 HRM [ SRS ]    PF02793 HRM [ Sanger ]    pfam02793 [ NCBI-CDD ]
PfamPF02354 Latrophilin [ SRS ]    PF02354 Latrophilin [ Sanger ]    pfam02354 [ NCBI-CDD ]
PfamPF02191 OLF [ SRS ]    PF02191 OLF [ Sanger ]    pfam02191 [ NCBI-CDD ]
SmartSM00303 GPS [EMBL]
SmartSM00008 HormR [EMBL]
SmartSM00284 OLF [EMBL]
ProdomPD005612 Gal_lectin[INRA-Toulouse]
ProdomO95490 LPHN2_HUMAN [ Domain structure ]   O95490 LPHN2_HUMAN  [ sequences sharing at least 1 domain ]
BlocksO95490
HPRD06116
Protein Interaction databases
DIPO95490
IntActO95490
Polymorphism : SNP, mutations, diseases
OMIM607018    [ map ]   
GENECLINICS607018
SNPLPHN2 [dbSNP-NCBI]  
SNPNM_012302 [SNP-NCI]  
SNPLPHN2 [GeneSNPs - Utah]  LPHN2] [HGBASE - SRS]
HAPMAPLPHN2 [HAPMAP]  
HGMDLPHN2
General knowledge
Family BrowserLPHN2 [UCSC Family Browser]
SOURCENM_012302
SMDHs.24212
SAGEHs.24212
GOmolecular_function [Amigo]  molecular_function
GOreceptor activity [Amigo]  receptor activity
GOG-protein coupled receptor activity [Amigo]  G-protein coupled receptor activity
GOsugar binding [Amigo]  sugar binding
GOcellular_component [Amigo]  cellular_component
GOplasma membrane [Amigo]  plasma membrane
GOsignal transduction [Amigo]  signal transduction
GOG-protein coupled receptor protein signaling pathway [Amigo]  G-protein coupled receptor protein signaling pathway
GOneuropeptide signaling pathway [Amigo]  neuropeptide signaling pathway
GObiological_process [Amigo]  biological_process
GOmembrane [Amigo]  membrane
GOintegral to membrane [Amigo]  integral to membrane
GOlatrotoxin receptor activity [Amigo]  latrotoxin receptor activity
PubGeneLPHN2
TreeFamLPHN2
CTD23266 [Comparative ToxicoGenomics Database]
Other databases
Probes
ProbeLPHN2 Related clones (RZPD - Berlin)
PubMed
PubMed10 Pubmed reference(s) in Entrez

Bibliography

Genomic structure and expression profile of LPHH1, a 7TM gene variably expressed in breast cancer cell lines.
White GR, Varley JM, Heighway J
Biochimica et biophysica acta. 2000 ; 1491 (1-3) : 75-92.
PMID 10760572
 
A family of heptahelical receptors with adhesion-like domains: a marriage between two super families.
Hayflick JS
Journal of receptor and signal transduction research. 2000 ; 20 (2-3) : 119-131.
PMID 10994649
 
REVIEW articlesautomatic search in PubMed
Last year publicationsautomatic search in PubMed

Search in all EBI   NCBI

Contributor(s)

Written11-2003Jim Heighway
Roy Castle International Centre for Lung Cancer Research, Liverpool, UK

Citation

This paper should be referenced as such :
Heighway J . LPHN2 (latrophilin 2). Atlas Genet Cytogenet Oncol Haematol. November 2003 .
URL : http://AtlasGeneticsOncology.org/Genes/LPHH1ID313.html

© Atlas of Genetics and Cytogenetics in Oncology and Haematology
indexed on : Tue Oct 14 21:21:16 2008


Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

For comments and suggestions or contributions, please contact us

j.l.huret@chu-poitiers.fr.